Reaction Details |
| Report a problem with these data |
Target | Serine/threonine-protein kinase 3 |
---|
Ligand | BDBM50583973 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2158673 (CHEMBL5043423) |
---|
Ki | 211±n/a nM |
---|
Citation | Bata, N; Chaikuad, A; Bakas, NA; Limpert, AS; Lambert, LJ; Sheffler, DJ; Berger, LM; Liu, G; Yuan, C; Wang, L; Peng, Y; Dong, J; Celeridad, M; Layng, F; Knapp, S; Cosford, NDP Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. J Med Chem65:1352-1369 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Serine/threonine-protein kinase 3 |
---|
Name: | Serine/threonine-protein kinase 3 |
Synonyms: | KRS1 | MST-2 | MST2 | Mammalian STE20-like protein kinase 2 | STE20-Like Kinase MST2 | STK3 | STK3_HUMAN | Serine/threonine-protein kinase 3 | Serine/threonine-protein kinase 3 (MST2) | Serine/threonine-protein kinase 3/4 | Serine/threonine-protein kinase Krs-1 | Serine/threonine-protein kinase MST2 |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 56284.87 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 491 |
Sequence: | MEQPPAPKSKLKKLSEDSLTKQPEEVFDVLEKLGEGSYGSVFKAIHKESGQVVAIKQVPV
ESDLQEIIKEISIMQQCDSPYVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLIE
DEIATILKSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT
VIGTPFWMAPEVIQEIGYNCVADIWSLGITSIEMAEGKPPYADIHPMRAIFMIPTNPPPT
FRKPELWSDDFTDFVKKCLVKNPEQRATATQLLQHPFIKNAKPVSILRDLITEAMEIKAK
RHEEQQRELEEEEENSDEDELDSHTMVKTSVESVGTMRATSTMSEGAQTMIEHNSTMLES
DLGTMVINSEDEEEEDGTMKRNATSPQVQRPSFMDYFDKQDFKNKSHENCNQNMHEPFPM
SKNVFPDNWKVPQDGDFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDA
MDAKKRRQQNF
|
|
|
BDBM50583973 |
---|
n/a |
---|
Name | BDBM50583973 |
Synonyms: | CHEMBL5093114 |
Type | Small organic molecule |
Emp. Form. | C17H16ClN3O |
Mol. Mass. | 313.781 |
SMILES | Clc1cccc(c1)-c1c[nH]c2nccc(N3CCOCC3)c12 |
Structure |
|